Flush with cash, Rakuten bil­lion­aire Mick­ey Mik­i­tani looks to take his pho­toim­munother­a­py plat­form glob­al

E-tail­er bil­lion­aire Mick­ey Mik­i­tani has backed As­pyr­i­an Ther­a­peu­tics’ pho­toim­munother­a­py tech from the be­gin­ning, start­ing as a par­tic­i­pant in the com­pa­ny’s $40 mil­lion Se­ries A round and lat­er tak­ing the helm as CEO and wrap­ping the brand en­tire­ly in­to his Rakuten em­pire.

He’s now reeled in an­oth­er $166 mil­lion to push the com­pa­ny’s lead head and neck can­cer drug through a glob­al Phase III tri­al.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER